About the Tufts Center for the Study of Drug Development (Tufts CSDD) The Tufts Center for the Study of Drug Development is an independent academic research center that conducts objective analyses of ...

Syneos Health announced findings from a first-of-its-kind benchmarking study conducted by the Tufts Center for the Study of Drug Development. The research examined one of the industry?s most ...

MORRISVILLE, N.C., Aug. 18, 2026 (GLOBE NEWSWIRE)-- Syneos Health®, a leading fully integrated biopharmaceutical solutions organization, today announced the continued advancement of its AI ecosystem - ...

MORRISVILLE, N.C., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced it is introducing a dedicated ...

The companies initially partnered to execute advanced causal AI models to optimize commercial programs, pivoting from time-intensive data science tools to faster, AI-driven decision-making to speed ...

(i) Syneos' business development capabilities had been materially impaired by workforce reductions and leadership and operational changes, as well as labor force turmoil caused by the COVID-19 ...

Good morning and welcome to the Syneos Health Third Quarter 2022 Earnings Conference Call. At this time all participants are in listen-only mode. Later we will conduct a question-and-answer session ...

causaLens, a London-based AI scaleup, today announced the expansion of its strategic partnership with Syneos Health, a leading fully integrated biopharmaceutical solutions organization, to advance the ...